trending Market Intelligence /marketintelligence/en/news-insights/trending/bgyxygafnx9qj_qn4inkya2 content esgSubNav
In This List

Valeritas complies with Nasdaq listing rules

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Valeritas complies with Nasdaq listing rules

Valeritas Holdings Inc. said it received a letter from Nasdaq stating the company was in compliance with listing rules.

The Nasdaq decision was based on the medical technology company's Form 10-Q disclosure for the period ended March 30, Valeritas said in an SEC filing.

The exchange had sent a notice to the New Jersey-based company in March saying it failed to comply with the requirements of minimum stockholders' equity at $2.5 million, market value of listed securities at $35 million and net income from continuing operations at $500,000.